Substantia nigra hyperechogenicity in Mexican patients with Parkinson’s disease
Objective: To determine the prevalence of increased echogenicity in the substantia nigra in patients diagnosed with idiopathic Parkinson's disease at the University Hospital "Dr. José…MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study
Objective: The aims of this study were to investigate which scale is best suited to assess cognition and more sensitive to cognitive decline over time…Neuropsychological assessment in a cohort of patients with Parkinson’s disease
Objective: To evaluate the cognitive profile in a cohort of patients with Parkinson's disease (PD) using a standardised battery. Background: Cognitive impairment is a great…Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment
Objective: Our aim is to assess CSF levels of amyloid-β1-42 (Aβ1-42), T-Tau, threonine-181 phosphorilated tau (P-Tau) and α-synuclein (α-syn) as well as different ratios of…How does cognition affect reaching in Parkinson’s disease?
Objective: To explore differences in kinematic parameters of reach in those with Parkinson's disease (PD) classified into normal cognition (PD-NC), mild cognitive impairment (PD-MCI) and…Longterm outcome of cognition following subthalamic deep brain stimulation in Parkinson´s disease
Objective: Longterm, “real-life” assessment of cognitive evolution following subthalamic (STN) deep brain stimulation (DBS) in patients suffering from Parkinson´s disease. Background: Anecdotal reports have speculated…Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)
Objective: To investigate the pattern of grey matter (GM) atrophy associated with cognitive decline in PD by use of voxel-based morphometry (VBM) analysis. Background: Loss…Attention and dopamine: Increased distractibility in Parkinson’s disease
Objective: To determine the interactions between dopamine, Working Memory(WM) and Attentional Control(AC) in Parkinson's disease(PD) patients. Background: WM impairment is common in PD. Studies have…Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease
Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance
Objective: To compare cognitive performance in patients with and without Impulse Control Disorders (ICD) according to MDS recommendations for Parkinson's disease (PD) Mild Cognitive Impairment…
- « Previous Page
- 1
- …
- 171
- 172
- 173
- 174
- 175
- …
- 207
- Next Page »